News
The Cambridge biotech believes packaging the two immunizations together will lead to higher uptake of COVID vaccines.
Moderna's flu vaccine shows positive late-stage trial results, paving way for combination Covid shot
The administration in May canceled a contract awarded to Moderna for the late-stage development of its bird flu vaccine for humans. When asked about the uncertain regulatory environment in the U.S., ...
WASHINGTON >> U.S. Senate Democrats demanded today that Health Secretary Robert F. Kennedy Jr. make public the reviews on ...
President Donald Trump's administration last month canceled a $590-million contract awarded to Moderna in January by outgoing ...
Moderna had already started a Phase 1/2 trial of its bird flu (H5N1) vaccine and reported strong early results. (HealthDay News) — The U.S. government has canceled a $600 million contract with ...
The Trump administration recently canceled $766 million in contracts with Moderna to develop and produce an mRNA vaccine against pandemic influenza viruses, including H5N1 avian flu. This is a tragic ...
An influenza vaccine candidate from Moderna showed promising results in a late-stage trial, bringing the drug maker one step ...
Of all the misguided decisions Robert F. Kennedy Jr. has made as secretary of Health and Human Services, canceling Moderna’s contract to develop a bird flu vaccine may be the most dangerous yet.
Amidst an ongoing outbreak of a deadly bird flu virus in livestock, the US Department of Agriculture is doing more to prevent ...
Hosted on MSN16d
Bird flu vaccine development funds awarded to Moderna amid multistate outbreak - MSNAvian influenza timeline: From chickens to foxes, here's how bird flu is spreading across the US If successfully developed, Moderna’s mRNA-based pandemic flu vaccine could improve response times ...
The topic recently made its way back into headlines when Moderna announced that the Trump administration was canceling a $766 million contract to develop a bird flu vaccine for humans.
In 2023, Moderna started a phase 1/2 study of an experimental pandemic influenza vaccines collectively known as mRNA-1018, which are designed to provide protection against H5 and H7 avian ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results